![\"\"](\"https:\/\/www.med.unc.edu\/obgyn\/wp-content\/uploads\/sites\/1360\/2023\/08\/hawkinsandzhang-300x150.jpg\")
The UNC OB-GYN Division of Gynecologic Oncology once again had an impressive presence at the Mid-Atlantic Gynecologic Oncology Meeting (MAGOS) in October 2019, with 14 presentations and three awards: Best Fellow Oral Presentation, Best Overall Poster, Best Medical Student Oral Presentation.<\/p>\n
Gabrielle M Hawkins, MD, won the Best Oral Presentation by a Gynecologic Oncology Fellow with her presentation, \u201cImpact of obesity on the uterine and gut microbiome in postmenopausal mice with and without endometrial cancer\u201d as well as Best Overall Poster Presentation with \u201cONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer.\u201d<\/p>\n
Yingao Zhang, MS, won Best Oral Presentation by a Medical Student with \u201cSurvival impact of neoadjuvant and adjuvant chemotherapy cycles stratified by interval debulking surgical approach in advanced epithelial ovarian cancer.\u201d<\/p>\n
The full list of abstracts is below:<\/p>\n
Contemporary Incidence of Medical Inoperability in Clinical Stage I Endometrial Cancer <\/strong><\/p>\n Ertel M, Staley SA, Johnson A, Nguyen T, Hopkins A, Desravines, N, Recknagel J, Clark LH<\/p>\n The Cdk1 inhibitor RO3306 has anti-tumorigenic effects in high grade serous ovarian cancer<\/strong><\/p>\n Sarah Paraghamian, Yu Huang, Gabrielle Hawkins, Yali Fan, Yajie Yin, Xin Zhang, Hongyan Suo, Chunxiao Zhou and Victoria Bae-Jump<\/p>\n Impact of obesity on the uterine and gut microbiome in postmenopausal mice with and without endometrial cancer<\/strong><\/p>\n Gabrielle Hawkins MD, Nikki McCoy BS, Wenchuan Sun MD, Temitope Keku PhD, Chunxiao Zhou, MD, PhD, Wendy R. Brewster MD PhD, Victoria L. Bae-Jump MD PhD<\/p>\n ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer<\/strong><\/p>\n Gabrielle M Hawkins, MD, MS,\u00a0Yali Fan, MD, Ziwei Fang, MD, Yu Huang, MD, Wenchuan Sun MD, Sarah Paraghamian, MD, Yajie Yin, MD, Varun Prabhu, PhD, Joshua E Allen, PhD, Chunxiao Zhou, MD, PhD, Victoria L Bae-Jump, MD, PhD<\/p>\n Retrospective analysis of prognostic factors impacting survival in patients with brain metastases of gynecologic origin <\/strong><\/p>\n Megan S. Grant MS, Yingao Zhang MS, Wesley Stepp MD\/PhD, Katherine Tucker MD, Allison Staley MD\/MPH, Leslie Clark MD<\/p>\n ONC206 exhibits anti-proliferative and anti-metastatic effects via activation of the integrated stress response in serous endometrial cancer in vitro <\/strong><\/p>\n Yingao Zhang MS, Yu Huang MD, Yajie Yin MD, Xiaoling Zhao MD, Yali Fan MD, Katherine Tucker MD, Allison Staley MD\/MPH, Varun Prabhu PhD, Joshua Allen PhD, Chunxiao Zhou MD\/PhD, Victoria Bae-Jump MD\/PhD<\/p>\n Survival impact of neoadjuvant and adjuvant chemotherapy cycles stratified by interval debulking surgical approach in advanced epithelial ovarian cancer <\/strong><\/p>\n Yingao Zhang MS, Megan Grant MS, Sarah Paraghamian MD, Leslie Clark MD<\/p>\n Highly potent dopamine receptor D2 antagonist ONC206 demonstrates antitumorigenic effect in endometrial cancer<\/strong><\/p>\n Allison Staley, MD, MPH, Katherine Tucker, MD, Ziwei Fang MD, Yali Fan, MD, Wenchuan Sun MD, Yajie Yin MD, Yingao Zhang, MS, Varun Vijay Prabhu, PhD, Joshua Allen, PhD, Martin Stogniew, PhD, Chunxiao Zhou, MD, PhD, Victoria L Bae-Jump, MD, PhD<\/p>\n The impact of an Enhanced Recovery After Surgery (ERAS) pathway on the\u00a0development of Acute Kidney Injury (AKI) in Gynecologic Oncology Patients<\/strong><\/p>\n Johnathon Recknagel, MD, Katherine Tucker, MD, Daniel Duncan, MSN, Brandon Gerringer, MS, Linda Van Le, MD<\/p>\n